AQR Arbitrage’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-16,631
Closed -$263K 468
2024
Q3
$263K Sell
16,631
-214,490
-93% -$3.38M 0.01% 326
2024
Q2
$3.53M Sell
231,121
-35,898
-13% -$544K 0.09% 191
2024
Q1
$4.38M Sell
267,019
-194,633
-42% -$3.07M 0.15% 150
2023
Q4
$6.76M Buy
461,652
+301,072
+187% +$4.2M 0.27% 102
2023
Q3
$2.31M Buy
160,580
+148,690
+1,251% +$2.32M 0.1% 213
2023
Q2
$195K Sell
11,890
-15,038
-56% -$245K 0.01% 475
2023
Q1
$450K Buy
+26,928
New +$434K 0.01% 506

Other funds holding BMEZ

AQR Arbitrage's BMEZ Position: Q4 2024 in Review

AQR Arbitrage sold out of BlackRock Health Sciences Trust II (BMEZ) in Q4 2024, closing a stake of 16,631 shares — an estimated $263K sold.

AQR Arbitrage first reported a position in BMEZ in Q1 2023 and held it in 7 quarters. The position peaked at $6.76M in Q4 2023. 103 funds tracked by Wall St. Rank hold BMEZ as of Q4 2024.

  • AQR Arbitrage reported no remaining BlackRock Health Sciences Trust II position as of Q4 2024 after selling out during the quarter.
  • AQR Arbitrage sold 16,631 BlackRock Health Sciences Trust II shares in Q4 2024, an estimated $263K.
  • AQR Arbitrage first reported a position in BlackRock Health Sciences Trust II in Q1 2023 and held it in 7 quarters.
  • AQR Arbitrage's BlackRock Health Sciences Trust II position peaked at $6.76M in Q4 2023.
  • 103 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q4 2024.

Based on AQR Arbitrage's 13F filing for Q4 2024, filed 14 Feb 2025.